Surrozen Inc. Common Stock (SRZN)

About SRZN

Surrozen, Inc., a biotechnology company, discovers and develops product candidates to selectively modulate the Wnt pathway for tissue repair. Its lead product candidates are antibody-based therapeutics that target various disease areas, including diseases of the eye, intestine, liver, lung, retina, kidney, cochlea, cornea, skin, pancreas, and central nervous system. The company develops SZN-814, which combines Frizzl…

Sector

Health Care

Industry

Biotechnology: Biological Products (No Diagnostic Substances)

Employees

44

Website

www.surrozen.com

Fundamentals

1-day range

$23.77$24.5

Market cap

$251.25M

P/E (trailing)

—

P/E (forward)

-5.25

EPS (trailing)

$-35.44

Dividend yield

—

Beta

0.53

Avg. volume

194.8K

Forecasts

4 analyst ratings

Surrozen Inc. Common Stock Competitors

Chosen by industry and closest market cap.

• SRZN

  Surrozen Inc. Common Stock

  $22.42

  ▼ 6.62%
  Market cap $251.25MP/E —
  $10.73$35
• TARA

  Protara Therapeutics Inc. Common Stock

  $3.82

  ▼ 4.26%
  Market cap $230.44MP/E —
  $3.02$7.82
• LCTX

  Lineage Cell Therapeutics Inc. Common Stock

  $1.11

  ▼ 4.31%
  Market cap $281.71MP/E —
  $1$2.09
• EDIT

  Editas Medicine Inc. Common Stock

  $3.15

  ▼ 4.55%
  Market cap $283.93MP/E —
  $1.66$4.54
• FATE

  Fate Therapeutics Inc. Common Stock

  $2.42

  ▼ 4.92%
  Market cap $290.23MP/E —
  $0.93$3.23
• SABS

  SAB Biotherapeutics Inc. Common Stock

  $3.79

  ▼ 3.56%
  Market cap $294.39MP/E 26.94
  $1.85$5.15
• NMRA

  Neumora Therapeutics Inc. Common Stock

  $1.38

  ▼ 6.76%
  Market cap $303.87MP/E —
  $0.83015$3.65

P/E shows — for peers not currently carrying a live signal of their own.

Latest news

• HC Wainwright & Co. Reiterates Buy on Surrozen, Maintains $44 Price Target
  benzinga · 8/10/2026
• HC Wainwright & Co. Reiterates Buy on Surrozen, Maintains $44 Price Target
  Benzinga · 8/10/2026

• TCG Crossover GP II, LLC · July 22, 2026 · Sale

  162.5K @ $21.25
• Andrew Pedrum Maleki · June 15, 2026 · Grant

  607 @ $19.01
• Yang Li · June 15, 2026 · Grant

  1.7K @ $8.11
• Craig C. Parker · June 15, 2026 · Grant

  1.6K @ $8.11
• Charles O. Williams · June 15, 2026 · Grant

  1.7K @ $8.11
• Tim Kutzkey · May 13, 2026 · Grant

  5.5K
• Haak-Frendscho Mary · May 13, 2026 · Grant

  5.5K
• CHAI CHRISTOPHER Y · May 13, 2026 · Grant

  5.5K
• Eric Bjerkholt · May 13, 2026 · Grant

  5.5K
• Rothenberg Mace · May 13, 2026 · Grant

  5.5K
• Berkenblit Anna · May 13, 2026 · Grant

  5.5K
• WOODHOUSE DAVID J · May 13, 2026 · Grant

  5.5K
• Craig C. Parker · May 4, 2026 · Sale

  4.5K @ $33.33
• Yang Li · May 4, 2026 · Sale

  1.6K @ $33.33
• Charles O. Williams · May 4, 2026 · Sale

  2.0K @ $33.33

Institutional Ownership

March 31, 2026

Total shares held

8.89M

Total value held

$256.21M

Institutional holders

55